Showing results (41-50 of 175) with videos related to
Sort By:
Pageof 18
Journal of Psychosomatic Research|September 18, 2012
Multiple sclerosis relapses and depressionPhil Moore, Claire Hirst, Katharine E Harding, et al.Journal of Extracellular Vesicles|September 30, 2017
Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosisJoanne L Welton, Samantha Loveless, Timothy Stone, et al.Journal of Neurology|May 22, 2025
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosisLaura Davies, Rasheed Shehadeh, W John Watkins, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2013
Demographic and clinical factors associated with changes in employment in multiple sclerosisPhil Moore, Katharine E Harding, Hannah Clarkson, et al.Human Brain Mapping|February 4, 2022
Fluctuations in EEG band power at subject-specific timescales over minutes to days explain changes in seizure evolutionsMariella Panagiotopoulou, Christoforos A Papasavvas, Gabrielle M Schroeder, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 14, 2012
Weight change associated with antiepileptic drugsWilliam Owen Pickrell, Arron S Lacey, Rhys H Thomas, et al.Epilepsy & Behavior : E&B|October 8, 2013
The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugsRhys H Thomas, Jane M Mullins, Carrie L Hammond, et al.Epilepsy & Behavior : E&B|May 14, 2014
Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsyJordana Walsh, Rhys H Thomas, Carla Church, et al.Journal of Neurology|March 5, 2009
The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based studyMark Wardle, Elisa Majounie, Mustapha B Muzaimi, et al.Neuroscience Letters|November 21, 2020
COVID-19 and psychosis risk: Real or delusional concern?Cameron J Watson, Rhys H Thomas, Tom Solomon, et al.Pageof 18